Cryo-Cell International Files 8-K

Ticker: CCEL · Form: 8-K · Filed: Sep 17, 2024 · CIK: 862692

Cryo Cell International Inc 8-K Filing Summary
FieldDetail
CompanyCryo Cell International Inc (CCEL)
Form Type8-K
Filed DateSep 17, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 8-K, corporate-event

TL;DR

CRYO-CELL INTERNATIONAL filed an 8-K, no major news yet, check full doc.

AI Summary

On September 13, 2024, CRYO-CELL INTERNATIONAL, INC. filed an 8-K report detailing an event under "Other Events." The filing does not contain specific financial figures or significant business updates, but serves as a notification to the SEC regarding a corporate event.

Why It Matters

This filing indicates a corporate event has occurred for Cryo-Cell International, requiring public disclosure. Investors should review the full filing for details on the nature of this event.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose any immediate financial risks or significant operational changes.

Key Players & Entities

  • CRYO-CELL INTERNATIONAL, INC. (company) — Registrant
  • September 13, 2024 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of Incorporation
  • 813 749-2100 (phone_number) — Registrant's Telephone Number

FAQ

What specific event is CRYO-CELL INTERNATIONAL, INC. reporting under 'Other Events'?

The provided text does not specify the exact nature of the 'Other Events' beyond it being a corporate disclosure requirement.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on September 13, 2024.

What is the state of incorporation for CRYO-CELL INTERNATIONAL, INC.?

The company is incorporated in Delaware.

What is the principal executive office address for CRYO-CELL INTERNATIONAL, INC.?

The principal executive offices are located at 700 Brooker Creek Blvd., Oldsmar, Florida 34677.

What is the Commission File Number for CRYO-CELL INTERNATIONAL, INC.?

The Commission File Number is 001-40767.

Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 13 · Accepted 2024-09-17 17:00:08

Key Financial Figures

  • $0.01 — nge on which registered Common Stock, $0.01 par value CCEL NYSE American LLC

Filing Documents

01 Other Events

Item 8.01 Other Events. The Board the Company has fixed October 29, 2024 as the date for the 2024 Annual Meeting of Stockholders of the Company (the "Annual Meeting"), and has fixed September 20, 2024 as the record date for determining stockholders entitled to notice of and to vote at the Annual Meeting. Stockholders intending to present business or director nominations at the Annual Meeting must submit the notice required by Article II, Section 3 of the Company's Bylaws (with respect to business other than director nominations) or Article II, Section 10 of the Company's Bylaws (with respect to director nominations) no later than the 10th calendar day following the day on which public disclosure of the date of the Annual Meeting is first made, which date of public disclosure is September 17, 2024. A copy of the Company's Bylaws, as amended, is included as Exhibit 3.1 to the Current Report on Form 8-K filed with the United States Securities and Exchange Commission on December 11, 2018. .

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Cryo-Cell International, Inc. Date: September 17, 2024 By: /s/ David Portnoy David Portnoy, Chairman and Co-CEO

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.